Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer

• Published in: Molecular biology reports Vol. 51; no. 1; p. 1030
• Main Authors: Erturk, Elif, Ari, Ferda, Onur, Omer Enes, Mustafa Gokgoz, Sehsuvar, Tolunay, Sahsine
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.12.2024; Springer Nature B.V
• Subjects: Adult; Aged; Animal Anatomy; Animal Biochemistry; Biomarkers; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Biomedical and Life Sciences; Breast cancer; Breast Neoplasms - diagnosis; Breast Neoplasms - genetics; Breast Neoplasms - pathology; ErbB-2 protein; Female; Gene Expression Regulation, Neoplastic; Histology; Humans; Life Sciences; Malignancy; Metastases; Metastasis; MicroRNAs; MicroRNAs - genetics; Middle Aged; miRNA; Morphology; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; Original Article; Prognosis; ROC Curve; Tumors; Cancer stem cell; miRNA; Biomarker; Breast cancer
• ISSN: 0301-4851; 1573-4978; 1573-4978
• DOI: 10.1007/s11033-024-09958-9

Background The most prevalent malignancy among women is breast cancer (BC). MicroRNAs (miRNAs) play a role in the initiation and progression of BC by influencing breast cancer stem cells (BCSCs) but the diagnostic and prognostic roles of those miRNAs on BC patients are still unknown. It was aimed to investigate expression profiles, diagnostic and prognostic potentials of BCSC-related miRNAs in different subtypes (Luminal A and B, HER2 + and TNBC) of BC patients. Methods and Results Expression analysis of 15 BCSC-related miRNAs was performed in 50 breast tumor tissues and 20 adjacent non-tumor tissues obtained from BC patients using the qRT-PCR method. The expression levels of miR-31 and miR-150-3p were significantly upregulated in the tumor tissues compared to the adjacent non-tumor tissues (p < 0.05). miR-31 expression upregulated in the Luminal A and Luminal B group compared to non-tumor tissue (p < 0.05). miR-31 expression was determined to be significantly higher in the Luminal group (Luminal A and B) compared to the aggressive group (HER2 + and TNBC) (p < 0.05). According to the ROC analysis, the area under the curve (AUC) of miR-31 and miR-150-3p were 0.66 with a sensitivity of 68% and a specificity of 70%. A significant inverse correlation was observed between miR-31 expression with metastatic carcinoma status, in situ component, and Ki67 value in tumors, and high miR-150-3p expression was correlated with p63 expression (p < 0.05). Conclusion miR-31 and miR-150-3p have the potential to serve as biomarkers for guiding diagnosis, evaluating prognosis, and metastatic process in patients with BC.